These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 24215280)

  • 1. Nanotechnologies for noninvasive measurement of drug release.
    Moore T; Chen H; Morrison R; Wang F; Anker JN; Alexis F
    Mol Pharm; 2014 Jan; 11(1):24-39. PubMed ID: 24215280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Therapeutic Nanomedicine.
    Joo J
    Adv Exp Med Biol; 2021; 1310():401-447. PubMed ID: 33834444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure.
    Khan AU; Khan M; Cho MH; Khan MM
    Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines.
    Dawidczyk CM; Kim C; Park JH; Russell LM; Lee KH; Pomper MG; Searson PC
    J Control Release; 2014 Aug; 187():133-44. PubMed ID: 24874289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.
    Sajja HK; East MP; Mao H; Wang YA; Nie S; Yang L
    Curr Drug Discov Technol; 2009 Mar; 6(1):43-51. PubMed ID: 19275541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the use of nanoparticles in cancer therapy and imaging.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional recruitment for drug delivery through protein-based nanotechnologies.
    Vazquez E; Mangues R; Villaverde A
    Nanomedicine (Lond); 2016 Jun; 11(11):1333-6. PubMed ID: 27221076
    [No Abstract]   [Full Text] [Related]  

  • 12. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
    Heneweer C; Gendy SE; Peñate-Medina O
    Ther Deliv; 2012 May; 3(5):645-56. PubMed ID: 22834408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview.
    Lungu II; Grumezescu AM; Volceanov A; Andronescu E
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31574993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic and diagnostic applications of nanoparticles.
    Youns M; Hoheisel JD; Efferth T
    Curr Drug Targets; 2011 Mar; 12(3):357-65. PubMed ID: 20955146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
    Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
    Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of nanotechnology for the treatment of cancer: Recent advances.
    Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
    Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
    Danhier F; Feron O; Préat V
    J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
    Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK
    Curr Med Chem; 2024; 31(28):4479-4494. PubMed ID: 37828674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique roles of nanotechnology in medicine and cancer.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.